A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy. [electronic resource]
Producer: 20190916Description: 72 p. digitalISSN:- 1550-7416
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Datasets as Topic
- Disease Progression
- Dose-Response Relationship, Drug
- Female
- Humans
- Male
- Middle Aged
- Models, Biological
- Neoplasm Grading
- Prognosis
- Progression-Free Survival
- Receptor, ErbB-2 -- metabolism
- Response Evaluation Criteria in Solid Tumors
- Stomach Neoplasms -- drug therapy
- Survival Analysis
- Trastuzumab -- administration & dosage
- Tumor Burden
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.